John Greene Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Greene.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Greene. John Greene is in WILLIS TOWERS WATSON PLC ($WSH) and Chief Financial Officer in WILLIS TOWERS WATSON PLC ($WSH) and EVP & Chief Financial Officer in Discover Financial Services ($DFS) and EVP, CFO and Treasurer in Bioverativ Inc. ($BIVV) and Director in CRISPR Therapeutics AG ($CRSP).
Latest Insider Trading Transactions of John Greene
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BIVV, CRSP, DFS, WSH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2021 | DFS | Discover Financial ... | Greene John | EVP & Chief Financi ... | Grant | A | 0.00 | 9,690 | 0 | 34,887 | 44.6 K to 34.9 K (-21.74 %) |
| Feb 03 2021 | DFS | Discover Financial ... | Greene John | EVP & Chief Financi ... | Payment of Exercise | F | 82.19 | 1,146 | 94,190 | 25,197 | 26.3 K to 25.2 K (-4.35 %) |
| Aug 03 2020 | DFS | Discover Financial ... | Greene John | EVP & Chief Financi ... | Payment of Exercise | F | 49.43 | 1,159 | 57,289 | 26,343 | 27.5 K to 26.3 K (-4.21 %) |
| Jun 15 2020 | CRSP | CRISPR Therapeutic ... | Greene John | Director | Option Exercise | A | 59.70 | 15,000 | 895,500 | 15,000 | |
| Jan 27 2020 | DFS | Discover Financial ... | Greene John | EVP & Chief Financi ... | Buy | P | 73.84 | 3,377 | 249,343 | 27,502 | 24.1 K to 27.5 K (+14.00 %) |
| Jan 24 2020 | DFS | Discover Financial ... | Greene John | EVP & Chief Financi ... | Grant | A | 0.00 | 11,198 | 0 | 24,125 | 12.9 K to 24.1 K (+86.62 %) |
| Sep 20 2019 | DFS | Discover Financial ... | Greene John | EVP & Chief Financi ... | Grant | A | 0.00 | 11,861 | 0 | 12,927 | 1.1 K to 12.9 K (+1,112.66 %) |
| Jun 13 2019 | CRSP | CRISPR Therapeutic ... | Greene John | Director | Option Exercise | A | 43.52 | 30,000 | 1,305,600 | 30,000 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | D | 44.51 | 56,615 | 2,519,934 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | D | 44.51 | 113,230 | 5,039,867 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | D | 0.00 | 42,727 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | D | 0.00 | 14,230 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Sell | D | 0.00 | 5,951 | 0 | 0 | 6 K to 0 (-100.00 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 7,114 | 0 | 14,230 | |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Payment of Exercise | F | 103.52 | 2,118 | 219,255 | 5,496 | 7.6 K to 5.5 K (-27.82 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Buy | M | 0.00 | 7,114 | 0 | 7,614 | 500 to 7.6 K (+1,422.80 %) |
| Feb 02 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | A | 0.00 | 42,727 | 0 | 42,727 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | A | 0.00 | 21,344 | 0 | 21,344 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | A | 44.51 | 113,028 | 5,030,876 | 113,028 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | A | 44.51 | 56,514 | 2,515,438 | 56,514 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | A | 0.00 | 21,344 | 0 | 21,344 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | A | 44.51 | 113,028 | 5,030,876 | 113,028 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | A | 44.51 | 56,514 | 2,515,438 | 56,514 | |
| Jan 06 2016 | WSH | WILLIS TOWERS WATS ... | Greene John | Grant | A | 0.00 | 3,913 | 0 | 14,805 | 10.9 K to 14.8 K (+35.93 %) | |
| Nov 12 2015 | WSH | WILLIS TOWERS WATS ... | Greene John | Chief Financial Off ... | Option Exercise | A | 44.05 | 39,964 | 1,760,414 | 39,964 | |
| Nov 12 2015 | WSH | WILLIS TOWERS WATS ... | Greene John | Chief Financial Off ... | Grant | A | 0.00 | 15,323 | 0 | 28,855 | 13.5 K to 28.9 K (+113.24 %) |
| Nov 12 2015 | WSH | WILLIS TOWERS WATS ... | Greene John | Chief Financial Off ... | Payment of Exercise | F | 44.14 | 804 | 35,489 | 13,532 | 14.3 K to 13.5 K (-5.61 %) |
| Dec 18 2014 | WSH | WILLIS TOWERS WATS ... | Greene John | Chief Financial Off ... | Option Exercise | A | 43.41 | 38,994 | 1,692,730 | 38,994 | |
| Dec 18 2014 | WSH | WILLIS TOWERS WATS ... | Greene John | Chief Financial Off ... | Grant | A | 0.00 | 5,183 | 0 | 14,336 | 9.2 K to 14.3 K (+56.63 %) |
| Aug 13 2014 | WSH | WILLIS TOWERS WATS ... | Greene John | Chief Financial Off ... | Grant | A | 0.00 | 9,153 | 0 | 9,153 | 0 to 9.2 K |
Page: 1